Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients
Main Authors: | Pierre Le Balc’h, Kieran Pinceaux, Charlotte Pronier, Philippe Seguin, Jean-Marc Tadié, Florian Reizine |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03252-3 |
Similar Items
-
Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
by: Sami Hraiech, et al.
Published: (2019-12-01) -
Phenoxazine Derivatives Inactivate Human Cytomegalovirus, Herpes Simplex Virus-1, and Herpes Simplex Virus-2 In Vitro
by: Kyoko Hayashi, et al.
Published: (2008-01-01) -
SEROEPIDEMIOLOGY OF TOXOPLASMA, RUBELLA, CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUS -2 IN WOMEN WITH BAD OBSTETRIC HISTORY. PART II. CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUS INFECTIONS
by: Abdulghani Mohamed Alsamarai, et al.
Published: (2013-10-01) -
Association of Tuberculosis and Infections of Herpes Simplex, Varicella Zoster Viruses and Cytomegalovirus
by: A. S. Kazanova, et al.
Published: (2015-08-01) -
Is the COVID-19 Pandemic a Good Time to Include <i>Aspergillus</i> Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience
by: Jean-Pierre Gangneux, et al.
Published: (2020-07-01)